Vera Therapeutics, Inc. (VERA)

NASDAQ: VERA · Real-Time Price · USD

40.53

-0.84 (-2.03%)

At close: Mar 20, 2026, 4:00 PM EDT

41.62

+1.09 (2.69%)

After-hours: Mar 20, 2026, 7:54 PM EDT

Vera Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-299.62	-152.15	-95.99	-89.06	-32.61
Depreciation & Amortization	0.47	0.11	0.02	-0.85	0.18
Stock-Based Compensation	37.93	20.8	11.49	8.89	3.01
Other Adjustments	-2.88	-6.1	-1.88	6.67	2.2
Changes in Other Operating Activities	22.99	2.66	-5.82	6.75	3.51
Operating Cash Flow	-241.1	-134.68	-92.18	-67.6	-23.71
Capital Expenditures	-0.63	-0.97	-0.06	-0.06	-
Purchases of Investments	-310.45	-703.02	-224.93	-148.49	-
Proceeds from Sale of Investments	506.16	278.96	185.56	78	-
Other Investing Activities	-0.8	-	-	-	-4.2
Investing Cash Flow	194.29	-425.03	-39.43	-70.55	-4.2
Long-Term Debt Issued	23.34	-	24.74	19.82	4.92
Net Long-Term Debt Issued (Repaid)	23.34	-	24.74	19.82	4.92
Issuance of Common Stock	306.98	645.91	116.06	88.21	51.73
Repurchase of Common Stock	-	-0.01	-	-	-
Net Common Stock Issued (Repurchased)	306.98	645.9	116.06	88.21	51.73
Other Financing Activities	-21.42	-39.23	-7.26	-6.1	-2.77
Financing Cash Flow	308.9	606.67	133.54	101.93	53.88
Net Cash Flow	262.08	46.97	1.93	-36.22	25.97
Free Cash Flow	-241.73	-135.65	-92.24	-67.66	-23.71
Free Cash Flow Per Share	-3.76	-2.45	-2.16	-2.55	-1.76
Levered Free Cash Flow	-253.45	-150.36	-77.11	-63.4	-24
Unlevered Free Cash Flow	-292.64	-165.38	-107.88	-85.07	-30.72

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q